Recent Finacing
Recent Raise
Tisbury Pharmaceuticals is a Boston-based pharmaceutical company developing therapies for glaucoma, advancing R-801 — an agent that lowers intraocular pressure by increasing trabecular meshwork outflow — into clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors